AXIM Biotechnologies, Inc. – OTC:AXIM
AXIM Biotechnologies stock price today
AXIM Biotechnologies stock price monthly change
AXIM Biotechnologies stock price quarterly change
AXIM Biotechnologies stock price yearly change
AXIM Biotechnologies key metrics
Market Cap | 4.67M |
Enterprise value | 11.39M |
P/E | -0.35 |
EV/Sales | 1861.02 |
EV/EBITDA | -1.09 |
Price/Sales | 971.34 |
Price/Book | -1.35 |
PEG ratio | N/A |
EPS | -0.02 |
Revenue | 85.34K |
EBITDA | -2.01M |
Income | -5.58M |
Revenue Q/Q | 616.22% |
Revenue Y/Y | 424.50% |
Profit margin | -218733.79% |
Oper. margin | -84792.1% |
Gross margin | 21.46% |
EBIT margin | -84792.1% |
EBITDA margin | -2362.43% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAXIM Biotechnologies stock price history
AXIM Biotechnologies stock forecast
AXIM Biotechnologies financial statements
| Jun 2023 | 9.92K | -3.72M | -37499.19% |
|---|---|---|---|
| Sep 2023 | 9.58K | 328.47K | 3428.35% |
| Dec 2023 | 12.85K | -1.90M | -14792.98% |
| Mar 2024 | 52.97K | -292.29K | -551.73% |
| Jun 2023 | 4246357 | 13.99M | 329.62% |
|---|---|---|---|
| Sep 2023 | 4043956 | 9.99M | 247.26% |
| Dec 2023 | 4146022 | 11.77M | 284.08% |
| Mar 2024 | 3954159 | 11.38M | 287.87% |
| Jun 2023 | -643.59K | 0 | 687.55K |
|---|---|---|---|
| Sep 2023 | -264.50K | 0 | 190.22K |
| Dec 2023 | 19.55K | 0 | 113.68K |
| Mar 2024 | -1.06M | -2.83K | 1.01M |
AXIM Biotechnologies alternative data
| Aug 2023 | 6 |
|---|---|
| Sep 2023 | 6 |
| Oct 2023 | 6 |
| Nov 2023 | 6 |
| Dec 2023 | 6 |
| Jan 2024 | 6 |
| Feb 2024 | 6 |
| Mar 2024 | 6 |
| Apr 2024 | 6 |
| May 2024 | 6 |
| Jun 2024 | 6 |
| Jul 2024 | 6 |
AXIM Biotechnologies other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2022 | 3861004 | 0 |
| Insider | Compensation |
|---|---|
| Mr. John W. Huemoeller II (1955) Pres, Chief Executive Officer & Director | $420,000 |
Mr. Robert T. Malasek (1968) Chief Financial Officer & Sec. | $36,000 |
-
What's the price of AXIM Biotechnologies stock today?
One share of AXIM Biotechnologies stock can currently be purchased for approximately $0.
-
When is AXIM Biotechnologies's next earnings date?
Unfortunately, AXIM Biotechnologies's (AXIM) next earnings date is currently unknown.
-
Does AXIM Biotechnologies pay dividends?
No, AXIM Biotechnologies does not pay dividends.
-
How much money does AXIM Biotechnologies make?
AXIM Biotechnologies has a market capitalization of 4.67M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 345.27% to 39.52K US dollars.
-
What is AXIM Biotechnologies's stock symbol?
AXIM Biotechnologies, Inc. is traded on the OTC under the ticker symbol "AXIM".
-
What is AXIM Biotechnologies's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of AXIM Biotechnologies?
Shares of AXIM Biotechnologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AXIM Biotechnologies's key executives?
AXIM Biotechnologies's management team includes the following people:
- Mr. John W. Huemoeller II Pres, Chief Executive Officer & Director(age: 70, pay: $420,000)
- Mr. Robert T. Malasek Chief Financial Officer & Sec.(age: 57, pay: $36,000)
-
How many employees does AXIM Biotechnologies have?
As Jul 2024, AXIM Biotechnologies employs 6 workers.
-
When AXIM Biotechnologies went public?
AXIM Biotechnologies, Inc. is publicly traded company for more then 11 years since IPO on 9 Oct 2013.
-
What is AXIM Biotechnologies's official website?
The official website for AXIM Biotechnologies is aximbiotech.com.
-
Where are AXIM Biotechnologies's headquarters?
AXIM Biotechnologies is headquartered at 6191 Cornerstone Court, East, San Diego, CA.
-
How can i contact AXIM Biotechnologies?
AXIM Biotechnologies's mailing address is 6191 Cornerstone Court, East, San Diego, CA and company can be reached via phone at 858 923 4422.
AXIM Biotechnologies company profile:
AXIM Biotechnologies, Inc.
aximbiotech.comOTC
6
Biotechnology
Healthcare
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
San Diego, CA 92121
CIK: 0001514946
ISIN: US05463V1008
CUSIP: 05463V100
